Dow Up 0.09% Nasdaq Down 0.02%

Progenics Pharmaceuticals, Inc. (PGNX)

-NasdaqGS
5.43 0.01(0.18%) Aug 27, 4:00PM EDT
Prev Close:5.44
Open:5.49
Bid:4.72 x 300
Ask:5.75 x 1000
1y Target Est:9.50
Beta:N/A
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:5.34 - 5.53
52wk Range:3.10 - 7.45
Volume:687,454
Avg Vol (3m):1,439,930
Market Cap:377.68M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PGNX

Comparison

Symbol% ChgMkt Cap
PGNXDown 0.18%377.68M
DNDN212.94M
NKTR1.82B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):53.09
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.22
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.93

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Progenics Pharmaceuticals, Inc. develops medicines for oncology. The company offers Relistor-subcutaneous injection for the treatment of opioid induced constipation (OIC) in advanced-illness patients receiving palliative care when laxative therapy... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback